NJ MCL Growth Makes Talcum Powder Cancer Lawsuit News
Potential plaintiffs following talcum powder ovarian cancer lawsuit news will likely take note of the growing number of actions transferred into multicounty litigation in New Jersey, which has risen by 27 since its November consolidation.
Monday, February 8, 2016 - The November multicounty consolidation of 103 lawsuits that made talcum powder ovarian cancer lawsuit news has seen the number of actions filed before a single New Jersey state judge grow to 130. The number of cases was reported to have grown by 27 in the latest case filing submitted on January 23.
The lawsuits in this multicounty litigation are filed in the home state of lead defendant Johnson & Johnson (J&J) and allege that the health care company marketed their talcum powder products to consumers without warning them about published research that suggests that talcum powder can lead to an increased risk of the contraction of ovarian cancer. J&J has claimed that the link does not exist, and that the research it did into finding significant links between talcum powder and ovarian cancer turned up no significant evidence supporting that claim.
The increase in the number of lawsuits filed before the Atlantic City Superior Court where they are consolidated speaks to the growing reach of talcum powder cancer lawsuit news, as more and more potential plaintiffs are hearing of the litigation and requesting for their actions to be transferred into multicounty litigation. Only 14 talcum powder lawsuits were filed in the 9 months since the first one transferred into multicounty litigation was filed in New Jersey.
The potential growth of talcum powder lawsuits nationwide is giant, as a Harvard doctor declared after conducting research into a talcum powder ovarian cancer lawsuit that as many as 10,000 women may contract ovarian cancer connected to talcum powder every year. The current number of talcum powder nationwide is well over 1,000 total, but the estimates given by the doctor and the steady growth of lawsuits in the New Jersey multicounty litigation indicate that this litigation may attract hundreds of additional lawsuits in the month to come, if not more.
J&J also advertised on its talcum powder products that they were meant to be used daily, further indicating that the number of potential plaintiffs in the U.S. could be sizeable. There have been talcum powder studies conducted that state that the correlation between talcum powder and ovarian cancer remained present even when the product was not used daily by a test subject. The plaintiffs have argued in numerous claims that despite these findings, J&J never attached warnings to their product informing consumers of a potential for an increased risk in ovarian cancer.
The New Jersey multicounty litigation was first transferred in November when 16 out of district lawsuits join 87 that had already been pending before the Atlantic City Superior Court. The transfer of the lawsuits made talcum powder lawsuit news as J&J is headquartered in New Jersey and suggested that the actions be consolidated in the Atlantic City Superior Court. The plaintiffs had requested that the 103 actions be consolidated to the Middlesex County Court, which was presiding over a smaller docket, but the New Jersey Supreme Court determined that since more than 75 percent of the lawsuits were already pending before the Atlantic City Superior Court, the 16 outstanding lawsuits should be transferred there before a single state judge.
The number of lawsuits is still expected to grow in the multicounty litigation. Updated case filings released on the New Jersey Courts website will continue to keep the public abreast of the talcum powder ovarian cancer lawsuit news related to the growth of the multicounty litigation against J&J.
OnderLaw, LLC -